Bristol Myers Squibb (BMY) EBIT Growth (5y) (2014 - 2026)

Bristol Myers Squibb (BMY) EBIT Growth (5y) (2014 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Bristol Myers Squibb - - 8.07 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.16%
Dec 31, 2025 27.77%
Sep 30, 2025 -5.55%
Jun 30, 2025 -8.33%
Mar 31, 2025 56.47%
Dec 31, 2024 -12.09%
Sep 30, 2024 -23.77%
Jun 30, 2024 -58.83%
Mar 31, 2024 -148.74%
Dec 31, 2023 -59.12%
Sep 30, 2023 -22.07%
Jun 30, 2023 1.70%
Mar 31, 2023 0.91%
Dec 31, 2022 4.06%
Sep 30, 2022 18.32%
Jun 30, 2022 -22.70%
Mar 31, 2022 -25.68%
Dec 31, 2021 -9.25%
Sep 30, 2021 -20.38%
Jun 30, 2021 -33.23%